U.K. mulls R&D tax credits for midsize biotechs

12/3/2004 | Reuters

The U.K.'s chancellor of the exchequer says he intends to review a tax credit given to medium-sized biotech and drug companies for research and development with an eye to increasing them as a way to encourage the industry. Gordon Brown also said he would end tax barriers that block spin-off companies created by universities. The drug industry applauded the promised move.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN